LSTA icon

Lisata Therapeutics
LSTA

Overview Fund Activity

34 hedge funds and large institutions have $5M invested in Lisata Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+1
Holders Change %
+3.03%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
7
Closed
4
Calls
$172K
Puts
$11K
Net Calls
+$161K
Net Calls Change
-$69K

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$399K
2
IIA
2
IPG Investment Advisors
California
$73K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$861K
4
UBS Group
4
UBS Group
Switzerland
$15K
5
TSS
5
Two Sigma Securities
New York
$10K

Top Sellers

1
BlackRock
1
BlackRock
New York
$452K
2
Two Sigma Investments
2
Two Sigma Investments
New York
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$36K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.4M
5
SM
5
Sabby Management
Florida
$1.24M
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
26
IFP Advisors
Florida
$1K – – –
SWM
27
Spire Wealth Management
Virginia
$1K +$1K +72 New
KFS
28
Kelly Financial Services
Massachusetts
$5 – – –
Two Sigma Investments
29
Two Sigma Investments
New York
– -$68K -6,289 Closed
Simplex Trading
30
Simplex Trading
Illinois
– -$13K -1,259 Closed
Citadel Advisors
31
Citadel Advisors
Florida
– -$13K -1,203 Closed
Citigroup
32
Citigroup
New York
– -$3K -300 Closed
1
2